Market Exclusive

Chemours Company (The) (NYSE:CC) reported earnings of $0.87 per share beating Walls Streets expectations.

Chemours Company (The) (NYSE:CC) reported Q2 2017 earnings this Afternoon, coming in at $0.87 per share, beating Wall Street’s estimates of $0.85 per Share. Revenue for the quarter came in at $1.59 billion beating analyst estimates of $1.49 billion

Analyst Coverage For Chemours Company (The) (NYSE:CC)
These are 6 Buy Ratings .
The current consensus rating for Chemours Company (The) (NYSE:CC) is Buy (Score: 3.00) with a consensus target price of $40.00 , a potential (16.61% downside)Recent Insider Trading for Chemours Company (The) (NYSE:CC)

Dividend History for Chemours Company (The) (NYSE:CC)

Recent Trading for Chemours Company (The) (NYSE:CC) Shares of Chemours Company (The) closed the previous trading session at 47.97 up +0.01 0.02% with 2,298,504 shares trading hands.

Exit mobile version